Cue Biopharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $61.5M
Liabilities Breakdown FY2023
Total Liabilities: $24.4M
Asset Breakdown
Total Assets: $61.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $48.5M | 78.8% |
| Accounts Receivable | $1.7M | 2.8% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $795.0K | 1.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $10.5M | 17.1% |
Liabilities Breakdown
Total Liabilities: $24.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.5M | 14.3% |
| Long-Term Debt | $4.2M | 17.2% |
| Other Liabilities | $16.7M | 68.5% |